세계의 랩온어칩 시장 보고서(2025년)
Lab On Chip Global Market Report 2025
상품코드 : 1855911
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,666,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,635,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,605,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

랩온어칩 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 78억 1,000만 달러에서 2025년에는 88억 5,000만 달러에 달하고, CAGR 13.3%로 확대될 전망입니다. 실적기간 내 성장은 환경 모니터링 채택 확대, 가정 검사 솔루션의 확대, 표적 치료를 위한 동반진단제의 사용 증가, 유행 대책에 대한 정부 자금 증가, 동물용 진단약 수요 증가가 견인했습니다.

랩온어칩 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 13.0%로 144억 2,000만 달러로 성장할 전망입니다. 예측 기간 내 성장은 실험실 자동화 및 워크플로 통합 개선, 웨어러블 랩온어칩 플랫폼의 출현, 저자원 환경에서의 임상시험 확대, 합성 생물학 용도에 대한 관심 증가, 식품 안전 검사에서의 사용 증가로 발생할 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 랩온어칩과 디지털 건강 생태계의 융합, 바이오 하이브리드 랩온어칩 시스템의 개발, 랩온어칩 데이터 무결성을 위한 블록체인의 채택, 구독 기반 진단 서비스 모델의 상승, 랩온어칩 및 CRISPR 기반 감지의 통합 등이 있습니다.

맞춤 의료 이용의 증가는 맞춤형 치료를 위한 신속하고 정확하며 비용 효율적인 유전자 분석을 제공하는 능력으로 랩온어칩 시장의 성장을 가속화할 것으로 예측됩니다. 맞춤 의료는 개인의 유전자 프로파일, 라이프 스타일, 환경에 따라 예방과 치료를 조정합니다. 맞춤 의료의 성장은 유전자 검사의 진보에 의해 촉진되고, 치료가 개인의 유전적 체질을 따르게 되어, 효과가 높아지고 부작용이 감소합니다. 랩온어칩 디바이스는 유전자 및 분자 데이터의 신속하고 정확한 분석을 용이하게 하며 기존의 검사 기술에 비해 시간과 비용을 절감하면서 맞춤형 치료를 가능하게 합니다. 예를 들어, 2024년 2월 미국의 비영리 단체인 맞춤의료연합(Personalized Medicine Coalition)은 FDA가 2023년에 희귀질환 치료를 위한 16개의 맞춤 치료를 승인했다고 보고했습니다. 따라서, 맞춤 의료의 이용 확대가 랩온어칩 시장을 뒷받침하고 있습니다.

랩온어칩 시장의 기업은 질병 모델링의 신속화와 맞춤 의료에 대한 응용을 강화하기 위해 오간온어칩 시스템과 같은 첨단 기술의 개발에 투자하고 있습니다. 이 미세 유체 장치는 인간 장기의 기능과 구조를 모방하고 신체 외부의 정확한 약물 검사 및 질병 모델링을 위한 생물학적 프로세스의 정확한 시뮬레이션을 제공합니다. 2023년 9월 프랑스에 본사를 둔 뉴로오간온어칩 기술 제공업체인 NETRI는 전임상시험의 속도와 예측성을 향상시키기 위해 설계된 오간온어칩 키트를 발표했습니다. 오간온어칩 시스템을 헬스케어 연구에 통합함으로써, 이 키트는 다양한 생물종의 세포 사용을 지원하고, 종 이상의 연구를 가능하게 하여, 예측적인 임상 인사이트를 제공합니다. 이 연구개발은 의약품 후보의 평가가 가속되고 동물실험에 대한 의존도를 줄이므로 의료연구에서 오간온어칩 기술의 채용이 크게 전진하게 됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Lab on chip (LOC) is a compact device that integrates multiple laboratory functions, including chemical analysis, biological assays, and diagnostics, onto a single chip. It precisely controls tiny fluid volumes, enabling faster, cost-effective, and high-throughput testing. LOC devices provide portable, efficient, and accurate laboratory analyses while minimizing reagent use and reducing turnaround times.

The primary types of lab on chip products and services include reagents and consumables, instruments, and software and services. Reagents and consumables are essential materials for performing biological and chemical assays. LOC devices employ technologies such as microfluidics, micro-electro-mechanical systems (MEMS), nanolithography, and three-dimensional (3D) printing, using materials such as polymers, glass, silicon, and paper. Applications span genomics, proteomics, point-of-care diagnostics, drug discovery, and other areas. Primary end users include biotechnology and pharmaceutical companies, hospitals, diagnostic centers, academic and research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The lab on chip market research report is one of a series of new reports from The Business Research Company that provides lab on chip market statistics, including the lab on chip industry global market size, regional shares, competitors with the lab on chip market share, detailed lab on chip market segments, market trends, opportunities, and any further data you may need to thrive in the lab on chip industry. This lab on chip market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lab on chip market size has grown rapidly in recent years. It will grow from $7.81 billion in 2024 to $8.85 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. Growth in the historic period was driven by increasing adoption of environmental monitoring, expansion of home-based testing solutions, rising use of companion diagnostics for targeted therapies, higher government funding for pandemic preparedness, and growing demand for veterinary diagnostics.

The lab on chip market size is expected to see rapid growth in the next few years. It will grow to $14.42 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. Growth in the forecast period is expected to result from improvements in lab automation and workflow integration, the emergence of wearable lab-on-chip platforms, expansion of clinical trials in low-resource settings, growing interest in synthetic biology applications, and increasing use in food safety testing. Primary trends anticipated for the forecast period include convergence of lab-on-chip and digital health ecosystems, development of biohybrid lab-on-chip systems, adoption of blockchain for lab-on-chip data integrity, rise of subscription-based diagnostic-as-a-service models, and integration of lab-on-chip with CRISPR-based detection.

The increasing use of personalized medicine is expected to drive the growth of the lab-on-chip market due to its ability to provide quick, accurate, and cost-efficient genetic analysis for customized treatments. Personalized medicine tailors prevention and treatment based on an individual's genetic profile, lifestyle, and environment. The growth of personalized medicine is fueled by advancements in genetic testing, allowing treatments to align with an individual's genetic makeup, which increases effectiveness and reduces side effects. Lab-on-chip devices facilitate rapid and precise analysis of genetic and molecular data, enabling personalized treatments while lowering both time and costs compared to traditional laboratory techniques. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization in the United States, reported that the FDA approved 16 personalized therapies in 2023 aimed at treating rare diseases, a significant increase from the six treatments approved in 2022. As a result, the expanding use of personalized medicine is boosting the lab-on-chip market.

Companies in the lab-on-chip market are investing in the development of advanced technologies, such as organ-on-chip systems, to speed up disease modeling and enhance applications in personalized medicine. These microfluidic devices mimic human organ functions and structures, offering precise simulations of biological processes for accurate drug testing and disease modeling outside the body. In September 2023, NETRI, a France-based provider of neuro-organs-on-chip technologies, introduced organ-on-chip kits designed to improve preclinical testing speed and predictiveness. By incorporating organ-on-chip systems into healthcare research, these kits support the use of cells from various species, enabling cross-species studies and delivering predictive clinical insights. This development accelerates drug candidate evaluation and reduces the reliance on animal testing, marking a significant advancement in the adoption of organs-on-chip technology in medical research.

In October 2024, Quris-AI, a US-based company focused on AI-driven drug development and safety prediction, acquired Nortis to strengthen its Bio-AI platform. The acquisition, for an undisclosed sum, enables Quris-AI to integrate Nortis's advanced organ-on-chip technologies into its platform, improving the predictive capabilities for preclinical drug testing. Nortis, based in the United States, is known for its microphysiology systems, including validated kidney-on-chip technologies, which are used in biomedical research and drug development.

Major players in the lab on chip market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd, QuantuMDx Group Ltd., InSphero, Micronit B.V., MesoBioTech, Mimetas, Achira Labs Pvt. Ltd., Elvesys, Beonchip, Lab Chip Technologies, and Sphere Bio.

North America was the largest region in the lab on chip market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lab on chip report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lab on chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab on chip market consists of revenues earned by entities by providing services such as medical diagnostics, drug development and screening, point-of-care testing, and cell and tissue studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab on chip market also includes sales of microfluidic analytical kits, genetic testing chips, organ-on-a-chip systems, and environmental monitoring chips. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab On Chip Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lab on chip market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lab on chip ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab on chip market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Lab On Chip Market Characteristics

3. Lab On Chip Market Trends And Strategies

4. Lab On Chip Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lab On Chip Growth Analysis And Strategic Analysis Framework

6. Lab On Chip Market Segmentation

7. Lab On Chip Market Regional And Country Analysis

8. Asia-Pacific Lab On Chip Market

9. China Lab On Chip Market

10. India Lab On Chip Market

11. Japan Lab On Chip Market

12. Australia Lab On Chip Market

13. Indonesia Lab On Chip Market

14. South Korea Lab On Chip Market

15. Western Europe Lab On Chip Market

16. UK Lab On Chip Market

17. Germany Lab On Chip Market

18. France Lab On Chip Market

19. Italy Lab On Chip Market

20. Spain Lab On Chip Market

21. Eastern Europe Lab On Chip Market

22. Russia Lab On Chip Market

23. North America Lab On Chip Market

24. USA Lab On Chip Market

25. Canada Lab On Chip Market

26. South America Lab On Chip Market

27. Brazil Lab On Chip Market

28. Middle East Lab On Chip Market

29. Africa Lab On Chip Market

30. Lab On Chip Market Competitive Landscape And Company Profiles

31. Lab On Chip Market Other Major And Innovative Companies

32. Global Lab On Chip Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lab On Chip Market

34. Recent Developments In The Lab On Chip Market

35. Lab On Chip Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기